tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

RxSight sees FY23 revenue $85M-$87M vs. prior $81M-$86M view

Consensus is $83.93M. Sees gross margin in the range of 60% to 61%, representing an implied increase of 36% to 39% compared to 2022, up from prior guidance of 58% to 60%. The company narrowed its 2023 operating expense guidance range of $106M-$107M, representing an implied increase of 25% to 26% compared to 2022.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on RXST:

Disclaimer & DisclosureReport an Issue

1